1. New DIA Program: Clinical Investigator Education, Training, and Certification

   • Jeffrey W. Sherman
   • W. David Watkins

   Guest Editorial 01 July 2003 Pages: 257 - 258

2. Development of a Patient Recruitment Program for Phase 2 Trials in a Biotechnology Company

   • Stacey M. Fung
   • Ellen Suen
   • Herbert B. Lee

   Clinical and Non - Clinical Drug Development 01 July 2003 Pages: 259 - 270

3. The Clinical Data Interchange Standards Consortium Laboratory Model: Standardizing Laboratory Data Interchange in Clinical Trials

   • Susan Bassion
   • The Clinical Data Interchange Standards Consortium Laboratory Data Standards Model Team

   Clinical and Non - Clinical Drug Development 01 July 2003 Pages: 271 - 281

4. Feasibility of Using the Med-eMonitor System in the Treatment of Schizophrenia: A Pilot Study

   • Paul E. Ruskin
   • Judy Van Der Wende
   • Bruce A. Kehr

   Clinical and Non - Clinical Drug Development 01 July 2003 Pages: 283 - 291

5. The Pursuit of Balance Using Stratified and Dynamic Randomization Techniques: An Overview

   • Damian J. McEntegart

   Statistics 01 July 2003 Pages: 293 - 308

6. Efficiency of General Estimating Equations Estimators of Slopes in Repeated Measurements: Adding Subjects or Adding Measurements?

   • Chul Ahn
   • Sin-Ho Jung

   Statistics 01 July 2003 Pages: 309 - 316

7. An Example of an Unblinded, Third-Party Interim Analysis for Sample Size Re-estimation

   • Simon Kirby
   • Scott McBride
   • Lohita Puvanarajan

   Statistics 01 July 2003 Pages: 317 - 320

8. The New European Union Good Agricultural and Collection Practice Rules: Are Good Practices Good Enough if They Do Not Result in Batch-to-Batch Consistency?

   • Willem K. Scholten

   Chemistry, Manufacturing, and Controls 01 July 2003 Pages: 321 - 327

9. Erratum to: Modeling the probability-cost-profitability architecture of portfolio management in the pharmaceutical industry

   • Andreas Zipfel

   Erratum 01 July 2003 Pages: 328 - 328

10. Impact of Disease Management on Cost-Effectiveness of Medicare Spending

    • Joshua Cohen
    • Cherie Poquetie

    Public Policy 01 July 2003 Pages: 329 - 339

11. A Primer on Bioterrorism: Potential Pathogens, Roles of United States Governmental Agencies, and Regulatory Models for Product Development

    • Colleen M. Dovenport

    Public Policy 01 July 2003 Pages: 341 - 352